Health Economics and Cancer Survivorship

[1]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[2]  C. Roehrborn,et al.  The economic burden of prostate cancer , 2011, BJU international.

[3]  Eric J Feuer,et al.  Projections of the cost of cancer care in the United States: 2010-2020. , 2011, Journal of the National Cancer Institute.

[4]  A. Mariotto,et al.  Burden of illness in adult survivors of childhood cancers , 2010, Cancer.

[5]  P. Bach.  Limits on Medicare's ability to control rising spending on cancer drugs. , 2009, The New England journal of medicine.

[6]  Alan Brennan,et al.  Systematic review of economic evidence for the detection, diagnosis, treatment, and follow-up of colorectal cancer in the United Kingdom , 2009, International Journal of Technology Assessment in Health Care.

[7]  Youngmee Kim,et al.  Time costs associated with informal caregiving for cancer survivors , 2009, Cancer.

[8]  P. Gibbs,et al.  Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial. , 2009, Journal of the National Cancer Institute.

[9]  Thomas J. Smith,et al.  American Society of Clinical Oncology guidance statement: the cost of cancer care. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Elizabeth Warren,et al.  Medical bankruptcy in the United States, 2007: results of a national study. , 2009, The American journal of medicine.

[11]  W. Lawrence,et al.  Inventory of Data Sources for Estimating Health Care Costs in the United States , 2009, Medical care.

[12]  L. Russell.  Completing Costs: Patients’ Time , 2009, Medical care.

[13]  Wendy Demark-Wahnefried,et al.  Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial. , 2009, JAMA.

[14]  Robert Pirker,et al.  Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial , 2009, The Lancet.

[15]  C. Earle,et al.  When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncology. , 2009, Journal of the National Cancer Institute.

[16]  E. Feuer,et al.  Estimates and projections of value of life lost from cancer deaths in the United States. , 2008, Journal of the National Cancer Institute.

[17]  E. Feuer,et al.  Productivity costs of cancer mortality in the United States: 2000-2020. , 2008, Journal of the National Cancer Institute.

[18]  Dongsheng Tu,et al.  K-ras mutations and benefit from cetuximab in advanced colorectal cancer. , 2008, The New England journal of medicine.

[19]  P. Cunningham.  Trade-offs getting tougher: problems paying medical bills increase for U.S. families, 2003-2007. , 2008, Tracking report.

[20]  E. Feuer,et al.  Projections of the costs associated with colorectal cancer care in the United States, 2000-2020. , 2008, Health economics.

[21]  E. Lamont,et al.  Evaluation of trends in the cost of initial cancer treatment. , 2008, Journal of the National Cancer Institute.

[22]  Angela Mariotto,et al.  Cost of care for elderly cancer patients in the United States. , 2008, Journal of the National Cancer Institute.

[23]  Daniel J. Freeman,et al.  Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  W. Lawrence,et al.  Economic evaluation alongside a clinical trial of psycho-educational interventions to improve adjustment to survivorship among patients with breast cancer. , 2008, Journal of Clinical Oncology.

[25]  E. Park,et al.  The economic burden of cancer in Korea in 2002. , 2008, European journal of cancer care.

[26]  Amy Y. Chen,et al.  Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. , 2008, The Lancet. Oncology.

[27]  R. Sandler,et al.  Value of Patient Time Invested in the Colonoscopy Screening Process: Time Requirements for Colonoscopy Study , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

[28]  J. Warren,et al.  Costs of cancer care in the USA: a descriptive review , 2007, Nature Clinical Practice Oncology.

[29]  Charles W. Given,et al.  Medicaid, Medicare, and the Michigan Tumor Registry: A Linkage Strategy , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[30]  Manuel Hidalgo,et al.  Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  D. Cunningham,et al.  Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment , 2007, British Journal of Cancer.

[32]  B. Jönsson,et al.  Cost of breast cancer in Sweden in 2002 , 2007, The European Journal of Health Economics.

[33]  E. Lamont,et al.  Patient time costs associated with cancer care. , 2007, Journal of the National Cancer Institute.

[34]  J. Banthin,et al.  Changes in financial burdens for health care: national estimates for the population younger than 65 years, 1996 to 2003. , 2006, JAMA.

[35]  Simon Stewart,et al.  Extending the Horizon in Chronic Heart Failure: Effects of Multidisciplinary, Home-Based Intervention Relative to Usual Care , 2006, Circulation.

[36]  E. Feuer,et al.  Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000–2020 , 2006, Cancer Causes & Control.

[37]  Martin L. Brown,et al.  Economic Impact of Cancer in the United States , 2006 .

[38]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[39]  Farin Kamangar,et al.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  M. Rukavina,et al.  Bankruptcy is the tip of a medical-debt iceberg. , 2006, Health affairs.

[41]  Steffie Woolhandler,et al.  Hope and hype: predicting the impact of electronic medical records. , 2005, Health affairs.

[42]  P. Ganz,et al.  Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  K. Knopf,et al.  Estimating Patient Time Costs Associated With Colorectal Cancer Care , 2005, Medical care.

[44]  H. D. de Vet,et al.  Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria , 2005, International Journal of Technology Assessment in Health Care.

[45]  D. Himmelstein,et al.  Illness and Injury as Contributors to Bankruptcy , 2005, Health affairs.

[46]  W. Lawrence,et al.  Burden of illness in cancer survivors: findings from a population-based national sample. , 2004, Journal of the National Cancer Institute.

[47]  Deborah Schrag,et al.  The price tag on progress--chemotherapy for colorectal cancer. , 2004, The New England journal of medicine.

[48]  K. Langa,et al.  Out-of-pocket health-care expenditures among older Americans with cancer. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[49]  K. Thorpe,et al.  National estimates of medical costs incurred by nonelderly cancer patients , 2004, Cancer.

[50]  D. Semmler,et al.  Innovative chemotherapies for stage III colon cancer: a cost-effectiveness study. , 2003, Hepato-gastroenterology.

[51]  K. Thorpe,et al.  Health insurance and spending among cancer patients. , 2003, Health affairs.

[52]  H. Sung,et al.  The economic burden of gynecologic cancers in California, 1998. , 2003, Gynecologic oncology.

[53]  L. Påhlman,et al.  Cost-effectiveness of preoperative radiotherapy in rectal cancer: results from the Swedish Rectal Cancer Trial. , 2002, International journal of radiation oncology, biology, physics.

[54]  Michael Pignone,et al.  Cost-Effectiveness Analyses of Colorectal Cancer Screening , 2002, Annals of Internal Medicine.

[55]  H. Sung,et al.  The economic burden of prostate cancer, California, 1998 , 2002, Cancer.

[56]  Ahmedin Jemal,et al.  Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden , 2002, Cancer.

[57]  D K Wagener,et al.  Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. , 2001, Journal of the National Cancer Institute.

[58]  J. Delisa.  A history of cancer rehabilitation , 2001, Cancer.

[59]  K. Langa,et al.  Estimating the cost of informal caregiving for elderly patients with cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  Ruth Etzioni,et al.  The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study. , 2001, Health economics.

[61]  J. Polder,et al.  Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study , 1998, BMJ.

[62]  L. Kessler,et al.  Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis , 1995, Medical care.

[63]  N Urban,et al.  Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. , 1995, Journal of the National Cancer Institute.

[64]  A. Culyer.  THE NORMATIVE ECONOMICS OF HEALTH CARE FINANCE AND PROVISION , 1989 .

[65]  H. Kraemer,et al.  Early Return to Work After Uncomplicated Myocardial Infarction , 1988 .

[66]  H. Kraemer,et al.  Early return to work after uncomplicated myocardial infarction. Results of a randomized trial. , 1988, JAMA.

[67]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[68]  A. Lilienfeld.  Foundations of Epidemiology , 1980 .

[69]  Aki Tsuchiya,et al.  Weighting Must Wait , 2012, PharmacoEconomics.

[70]  M. Postma,et al.  Cost Considerations in the Treatment of Colorectal Cancer , 2012, PharmacoEconomics.

[71]  J. Warren,et al.  Linking Tumor Registry and Medicaid Claims to Evaluate Cancer Care Delivery , 2009, Health care financing review.

[72]  Anthony J. Culyer,et al.  Comprar Economic Evaluation of Interventions for Occupational Health and Safety Developing Good Practice | Emile Tompa | 9780199533596 | Oxford University Press , 2008 .

[73]  Anthony J. Culyer,et al.  Economic Evaluation of Interventions for Occupational Health and Safety: Developing Good Practice , 2008 .

[74]  Patricia A. Ganz,et al.  From cancer patient to cancer survivor : lost in transition , 2006 .

[75]  W. Shadish,et al.  Experimental and Quasi-Experimental Designs for Generalized Causal Inference , 2001 .

[76]  K. Schulman,et al.  Treatment choices by seriously ill patients: the Health Stock Risk Adjustment model. , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[77]  C. Somkin,et al.  Cost of Care for Cancer in a Health Maintenance Organization , 1997, Health care financing review.

[78]  P Boffetta,et al.  Socioeconomic differences in cancer incidence and mortality. , 1997, IARC scientific publications.

[79]  M. Kogevinas,et al.  Socioeconomic differences in cancer survival: a review of the evidence. , 1997, IARC scientific publications.

[80]  M. Kogevinas,et al.  Social inequalities and cancer , 1997 .

[81]  M. Koopmanschap,et al.  Current and future costs of cancer. , 1994, European journal of cancer.

[82]  A. Mcguire,et al.  Providing health care : the economics of alternative systems of finance and delivery , 1991 .